| Geneblue Corporation Patent applications |
| Patent application number | Title | Published |
|---|
| 20120082736 | Small-molecule TNF modulator to reduce the side effects of chemotherapy and radiotherapy - Cancer patients treated by chemotherapy and/or radiotherapy often suffer serious side effects. Currently, there is only one FDA approved and used as both a chemoprotector and a radioprotector, amifostine, which is associated with significant problems. Disclosed in the present invention are novel methods of using UTL-5g as both a chemoprotector and radioprotector for treating cancer patients in addition to other related methods. | 04-05-2012 |
| 20090042958 | Composition and method for treating immune-mediated skin disorders - Liquid or semi-liquid pharmaceutical compositions for topically treating immune-mediated skin disorders such as psoriasis, eczema, acne, dermatitis, and skin cancer and methods of treating patients having such immune-mediated skin disorders using the compositions. | 02-12-2009 |
